Navigation Links
IDEXX Laboratories Announces Increase in Share Repurchase Program
Date:2/15/2008

WESTBROOK, Maine, Feb. 15 /PRNewswire-FirstCall/ -- IDEXX Laboratories, Inc. (Nasdaq: IDXX), announced today that its Board of Directors has authorized the repurchase by the Company of an additional four million shares of its common stock under its ongoing share repurchase program. Repurchases will be made in the open market or in negotiated transactions. These shares are in addition to the 2,852,000 shares remaining as of December 31, 2007, under a previous Board authorization. The timing and amount of any repurchases will be at the discretion of the Company's management.

About IDEXX Laboratories

IDEXX Laboratories, Inc. is a leader in companion animal health, serving practicing veterinarians around the world with innovative, technology-based offerings, including a broad range of diagnostic products and services, practice management systems and pharmaceuticals. IDEXX products enhance the ability of veterinarians to provide advanced medical care and to build more economically successful practices. IDEXX is also a worldwide leader in providing diagnostic tests and information for the production animal industry and tests for the quality and safety of water and milk. Headquartered in Maine, IDEXX Laboratories employs more than 4,500 people and offers products to customers in over 100 countries.

Contact: Merilee Raines, Chief Financial Officer, 1-207-556-8155


'/>"/>
SOURCE IDEXX Laboratories, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. IDEXX Laboratories to Present at JPMorgan Healthcare Conference
2. IDEXX Laboratories to Release 2007 Fourth Quarter and Full-Year Financial Results
3. IDEXX Laboratories Announces Fourth Quarter Results
4. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
6. Planet Technologies Announces Agreement to Acquire Antigen Laboratories
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
8. Sandia National Laboratories Selects Allscripts Electronic Health Record and Practice Management for Employee Health Center
9. Andrew Lessmans TWC Construction and ProCaps Laboratories Contract With DT Solar to Install a 700 kW Solar Electric System
10. Mesa Laboratories Names New Vice President of Sales and Marketing
11. Caraco Pharmaceutical Laboratories Ltd. Announces Tentative FDA Approval for Generic Zyrtec Chewable(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/25/2017)... , ... September 25, 2017 , ... ... the LGBTQ Community”: a gripping look at the religious stand in the ... teachings of love and compassion. “The Ministry of Reconciliation: A Compassionate and Realistic ...
(Date:9/25/2017)... ... September 25, 2017 , ... Netmail, Inc . and ... Hadron Data Auditing and eDiscovery services to healthcare organizations as ... Hadron solution in a HIPAA/HITRUST Azure Cloud at the Microsoft Ignite #MSIgnite conference in ...
(Date:9/25/2017)... ... September 25, 2017 , ... ... Workshop, **Presented by FDAnews**, Nov. 1-3, 2017 – Bethesda, MD, http://www.fdanews.com/fdainspectionssummit ... flying colors. And then, on the tenth inspection it failed. , What went ...
(Date:9/24/2017)... BRAMTON, Ontario (PRWEB) , ... September 25, 2017 , ... ... (published by iUniverse) explores the fundamental questions of life and seeks answers in both ... Christianity . , “The searching for God is in the mind of humankind for ...
(Date:9/24/2017)... ... September 23, 2017 , ... Throughout the United States and the world, clinicians ... physicians, nurses and other providers work to give the best care possible to patients ... But U.S. Senators today are threatening to tie our hands in carrying out that ...
Breaking Medicine News(10 mins):
(Date:9/7/2017)... 2017   BioLife Solutions , Inc. (NASDAQ: ... clinical grade cell and tissue hypothermic storage and ... Rice , President and CEO, will be presenting at two ... & Renshaw 19 th Annual Global Investment Conference on ... Pacific time). The conference is being held at the New ...
(Date:9/6/2017)... --  PDI , a leader in infection prevention products ... session focused on the role of chlorhexidine gluconate (CHG) ... 2017 Annual Scientific Meeting of the Association for Vascular ... Phoenix Convention Center in ... also feature PDI,s Prevantics® Device Swab as ...
(Date:9/5/2017)... -- Sapheneia and Scannerside received FDA 510(k) clearance to ... third-party Vendor neutral CT product that makes it affordable ... current MITA standards. ... specifically designed to provide CT operators, prior to a ... a predefined threshold. Scannerside Dose Check is intended to ...
Breaking Medicine Technology: